Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Alibaba Sells Medical Assets to Hong Kong Arm for $1.4 Billion

Published 2018-05-28, 09:28 p/m
Updated 2018-05-28, 11:18 p/m
© Reuters.  Alibaba Sells Medical Assets to Hong Kong Arm for $1.4 Billion

© Reuters. Alibaba Sells Medical Assets to Hong Kong Arm for $1.4 Billion

(Bloomberg) -- Alibaba (NYSE:BABA) Group Holding Ltd. is selling assets from medical devices to drugs for HK$10.6 billion ($1.4 billion) to a Hong Kong-listed unit that it’ll take control of and turn into its main healthcare arm.

Alibaba unveiled a deal Tuesday under which it will inject a plethora of businesses -- from its online Tmall pharmacy to adult products such as condoms --- into Alibaba Health Information Technology Ltd., in return for HK$10.6 billion worth of new stock in the affiliate. It will control a 56.2 percent economic interest and 67.5 percent of the voting interest in the company after the transaction.

China’s leading e-commerce operator is pushing deeper into a state-dominated healthcare sector, vowing to transform an outmoded model with data and cloud computing. By taking outright control of the business, Alibaba can connect better with customers, smooth operations and allow the unit to take the lead in expanding Alibaba’s footprint in a Chinese market estimated at 4.6 trillion yuan ($719 billion). Alibaba’s steadily folded in the disparate strands of its sprawling empire from logistics arm Cainiao and video service Youku to its southeast Asian e-commerce platform Lazada.

“Healthcare is a strategically important area for Alibaba Group with strong growth potential,” Chief Executive Officer Daniel Zhang said in the statement. “This transaction is a logical evolution for the continued development of Alibaba Health into our healthcare flagship platform.”

The transaction remains subject to the approval of independent Alibaba Health shareholders and the Hong Kong Stock Exchange.

Alibaba’s announcement follows almost two weeks of frenetic trading in Alibaba Health, which had rallied about as much as 60 percent since mid-May -- ranking it one of the best-performing stocks on the MSCI Asia Pacific Index for the month. The company remains mired in losses and until last week, its stock wasn’t covered by a single analyst. The stock rose another 5.8 percent in pre-market trade Tuesday.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.